Literature DB >> 29257238

Necrostatin-1 attenuates sepsis-associated acute kidney injury by promoting autophagosome elimination in renal tubular epithelial cells.

Wei Dong1, Zhilian Li1, Yuanhan Chen1, Li Zhang1, Zhiming Ye1, Huaban Liang1, Ruizhao Li1, Lixia Xu1, Bin Zhang1, Shuangxin Liu1, Weidong Wang2, Chunling Li2, Wei Shi1, Xinling Liang1.   

Abstract

The aim of the present study was to investigate the protective effect of necrostatin‑1 (Nec‑1) in sepsis‑associated acute kidney injury (SA‑AKI). An SA‑AKI mouse model was established through an intraperitoneal injection of lipopolysaccharide (LPS), and Nec‑1 was administered to the mice prior to the establishment of SA‑AKI. Renal function and histological changes were evaluated, and the expression levels of microtubule‑associated protein light chain 3‑II (LC3‑II) and p62, as markers of autophagic flux, were detected. Autophagosomes and autolysosomes in renal tubular epithelial cells were also identified using electron microscopy. Pretreatment with Nec‑1 could attenuate the LPS‑induced increases in the concentrations of blood urea nitrogen (LPS+Nec‑1 vs. LPS group, 14.15±4.14 mmol/l vs. 32.54±5.46 mmol/l, respectively; P<0.001) and serum creatinine (11.50±1.67 µmol/l vs. 30.08±4.18 µmol/l, respectively; P<0.001). However, there were no significant differences in the rate of renal tubular epithelial cell necrosis between the groups. In the renal tissues of SA‑AKI mice, protein analysis showed that the LC3‑II and p62 proteins were increased, while a reverse transcription‑quantitative Reverse transcription‑polymerase chain reaction analysis detected no increase in LC3‑II or p62 mRNA. Additionally, a high number of autophagosomes, but not of autolysosomes, were observed by electron microscopy. When mice were pretreated with Nec‑1, the levels of LC3‑II and p62 decreased, and a large number of autolysosomes were observed by electron microscopy in the Nec‑1 pretreatment group. These results indicated that Nec‑1 improved autophagosome elimination, a process that is impaired by LPS, in renal tubular epithelial cells. This potentially enabled Nec‑1 to prevent SA‑AKI. Furthermore, the findings suggested that the protective effect of Nec‑1 may not have involved the inhibition of necroptosis, but may have occurred through the promotion of autophagosome elimination in renal tubular epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29257238     DOI: 10.3892/mmr.2017.8214

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

1.  miR-425-5p improves inflammation and septic liver damage through negatively regulating the RIP1-mediated necroptosis.

Authors:  Changwei Gu; Chongzhi Hou; Sheng Zhang
Journal:  Inflamm Res       Date:  2020-01-30       Impact factor: 4.575

Review 2.  Mitochondria as mediators of systemic inflammation and organ cross talk in acute kidney injury.

Authors:  Mark Hepokoski; Prabhleen Singh
Journal:  Am J Physiol Renal Physiol       Date:  2022-04-04

3.  Lipopolysaccharide induces human olfactory ensheathing glial apoptosis by promoting mitochondrial dysfunction and activating the JNK-Bnip3-Bax pathway.

Authors:  Maowei He; Zimin Xiang; Libin Xu; Yanting Duan; Fangqin Li; Jianmei Chen
Journal:  Cell Stress Chaperones       Date:  2018-10-29       Impact factor: 3.667

4.  RIP3 impedes transcription factor EB to suppress autophagic degradation in septic acute kidney injury.

Authors:  Ruizhao Li; Xingchen Zhao; Shu Zhang; Wei Dong; Li Zhang; Yuanhan Chen; Zhilian Li; Huan Yang; Ying Huang; Zhiyong Xie; Weidong Wang; Chunling Li; Zhiming Ye; Zheng Dong; Xinling Liang
Journal:  Cell Death Dis       Date:  2021-06-08       Impact factor: 8.469

Review 5.  RIPK3: A New Player in Renal Fibrosis.

Authors:  Ying Shi; Xinming Chen; Chunling Huang; Carol Pollock
Journal:  Front Cell Dev Biol       Date:  2020-06-16

6.  Necrostatin-1 Attenuates Cisplatin-Induced Nephrotoxicity Through Suppression of Apoptosis and Oxidative Stress and Retains Klotho Expression.

Authors:  Yichun Ning; Yiqin Shi; Jing Chen; Nana Song; Jieru Cai; Yi Fang; Xiaofang Yu; Jun Ji; Xiaoqiang Ding
Journal:  Front Pharmacol       Date:  2018-04-19       Impact factor: 5.810

7.  Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target.

Authors:  Lauren Mifflin; Dimitry Ofengeim; Junying Yuan
Journal:  Nat Rev Drug Discov       Date:  2020-07-15       Impact factor: 112.288

8.  Overexpressed CD39 mitigates sepsis‑induced kidney epithelial cell injury via suppressing the activation of NLR family pyrin domain containing 3.

Authors:  Meixia Yang; Linxin Lu; Zhiqin Kang; Tianlong Ma; Yu Wang
Journal:  Int J Mol Med       Date:  2019-09-23       Impact factor: 4.101

9.  Necrostatin-1 Ameliorates Neutrophilic Inflammation in Asthma by Suppressing MLKL Phosphorylation to Inhibiting NETs Release.

Authors:  X A Han; H Y Jie; J H Wang; X M Zhang; Jun Wang; C X Yu; J L Zhang; J He; J Q Chen; K F Lai; E W Sun
Journal:  Front Immunol       Date:  2020-04-24       Impact factor: 7.561

10.  Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.

Authors:  Fanghong Mou; Canglang Mou
Journal:  Med Sci Monit       Date:  2020-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.